Filing Details
- Accession Number:
- 0001209191-21-062822
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-03 19:13:58
- Reporting Period:
- 2021-11-01
- Accepted Time:
- 2021-11-03 19:13:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1679363 | Morphic Holding Inc. | MORF | Pharmaceutical Preparations (2834) | 473878772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1773184 | Marc Schegerin | C/O Morphic Holding, Inc. 35 Gatehouse Drive, A2 Waltham MA 02451 | Cfo And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-01 | 5,477 | $15.00 | 12,003 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-11-01 | 5,477 | $60.00 | 6,526 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-11-02 | 6,666 | $15.00 | 13,192 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2021-11-01 | 5,477 | $0.00 | 5,477 | $15.00 |
| Common Stock | Stock Option (right to buy Common Stock) | Disposition | 2021-11-02 | 6,666 | $0.00 | 6,666 | $15.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 190,600 | 2030-04-05 | No | 4 | D | Direct | |
| 183,934 | 2030-04-05 | No | 4 | D | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- The option vests as to 25% of the total shares on April 6, 2021, and then 1/48 of the total shares vest monthly thereafter, with 100% of the total shares vested and exercisable on April 6, 2024, subject to the reporting person's provision of service to the Issuer on each vesting date.
Billionaire Hedge Funds
